Trials / Unknown
UnknownNCT03702933
D-serine in Schizophrenia
The Effects of Add-On D-serine Pharmacotherapy in Chronic Treatment Resistant Schizophrenia Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Herzog Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the effects of D-serine adjuvant treatment to the ongoing pharmacological treatment of schizophrenia patients that are resistant to treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | D-serine | dosage |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2021-09-01
- Completion
- 2021-12-01
- First posted
- 2018-10-11
- Last updated
- 2018-10-11
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03702933. Inclusion in this directory is not an endorsement.